Aleafia Competitors

Delisted . USA . 
Stock . Aleafia Health
ALEAFDelisted Stock  USD 0.02  0.00  0.00%   
Aleafia Health competes with Verano Holdings, and Grown Rogue; as well as few others. The company classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. Analyzing Aleafia Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Aleafia Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Aleafia Health competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.010.020.02
Details
Intrinsic
Valuation
LowRealHigh
0.010.010.02
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Aleafia Health. Your research has to be compared to or analyzed against Aleafia Health's peers to derive any actionable benefits. When done correctly, Aleafia Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Aleafia Health.

Aleafia Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Aleafia Health and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Aleafia and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Aleafia Health does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
KAYS
+ 0.82
VRNOF
PHBI
+ 0.72
VRNOF
KAYS
+ 0.71
PHBI
VRNOF
+ 0.7
ACRHF
PHBI
+ 0.59
ACRHF
EDXC
+ 0.56
ACRHF
  
High negative correlations   
TRSSF
- 0.39
CCHWF
MPXOF
- 0.36
VRNOF
EDXC
- 0.31
TRSSF
MPXOF
- 0.29
PHBI
TRSSF
- 0.27
VRNOF
TRSSF
- 0.26
ACRHF

Risk-Adjusted Indicators

There is a big difference between Aleafia Pink Sheet performing well and Aleafia Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aleafia Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ACRHF  8.36 (2.62) 0.00  3.84  0.00 
 0.00 
 11.11 
(16.67)
 117.00 
CCHWF  4.16  0.11  0.01 (0.34) 5.68 
(5.84)
 10.53 
(6.52)
 39.88 
VRNOF  4.05 (1.30) 0.00  1.14  0.00 
 0.00 
 6.56 
(8.52)
 38.88 
TRSSF  2.82  0.02  0.01  0.05  3.35 
(3.26)
 6.83 
(5.99)
 15.51 
PHBI  7.72 (0.68) 0.00 (1.06) 0.00 
 0.00 
 17.65 
(15.91)
 42.45 
MYCOF  24.19  4.61  0.15  0.48  19.61 
(49.11)
 55.56 
(33.93)
 180.56 
EDXC  6.16 (0.24) 0.00 (0.23) 0.00 
 0.00 
 15.84 
(14.53)
 36.65 
GGBXF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
MPXOF  87.01  40.63  0.49  1.78  26.51 
(360.19)
 450.00 
(81.82)
 1,292 
KAYS  5.87 (0.25) 0.00 (0.84) 0.00 
 0.00 
 15.89 
(13.98)
 45.86 
All Fundamental Data

Aleafia Health Competitive Analysis

The better you understand Aleafia Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Aleafia Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Aleafia Health's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ALEAF ACRHF CCHWF VRNOF TRSSF PHBI MYCOF EDXC MPXOF KAYS
 0.00 
 0.02 
Aleafia
 0.00 
 0 
Acreage
 4.55 
 0.46 
Columbia
 1.64 
 1.20 
Verano
 1.90 
 1.55 
Terrascend
 6.25 
 0 
Pharmagreen
 20.00 
 0 
Mydecine
 10.53 
 0.01 
Endexx
 81.82 
 0.0002 
MPX
 9.17 
 0.03 
Kaya
Market Volatility
(90 Days Market Risk)
Somewhat reliable
Out of control
Very steady
Abnormally volatile
Very steady
Out of control
Out of control
Out of control
Out of control
Out of control
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
OK
Very Weak
Solid
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Quite High
Dangerous
Above Average
Dangerous
Below Average
High
Below Average
About Average
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Under Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Not Rated
Strong Sell
Not Rated
Strong Sell
Sell
Strong Sell
Cautious Hold
Strong Sell
Current Ratio
1.2
1.5
1.17
0.49
0.98
0.1
1.26
0.05
0.47
0.02
Net Asset
N/A
491.55 M
1.38 B
2.55 B
581.93 M
208.97 K
7.58 M
5.22 M
50.67 M
1.57 M
Profit Margin
-1.6
-0.36
-0.32
-0.0204
-1.4
N/A
N/A
N/A
N/A
N/A
EBITDA
(16.57 M)
(21.13 M)
(63.7 M)
212.47 M
77.14 M
(828.26 K)
(23.14 M)
(2.87 M)
(16.01 M)
11.26 M
Operating Margin
-0.69
-0.0205
-0.12
0.14
-0.12
N/A
N/A
-2.63
-2.56
-1.57
Current Valuation
54.76 M
289.41 M
1.04 B
1.53 B
699.2 M
3.12 M
8.64 M
33.07 M
18.4 M
8.85 M
Price To Book
1.11
0.57
0.96
0.74
1.65
N/A
23.41
N/A
0.19
N/A
Retained Earnings
N/A
N/A
N/A
N/A
N/A
N/A
N/A
(11.24 M)
N/A
(10.89 M)
Current Asset
N/A
N/A
N/A
N/A
N/A
N/A
N/A
122 K
N/A
105 K
Beta
1.67
2.96
2.01
N/A
1.97
1.44
3.42
1.17
0.82
0.24
Number Of Employees
162
1.09 K
2.59 K
3.89 K
742
4
11
6
5
4
Shares Outstanding
403.04 M
78.83 M
400.44 M
324.32 M
282.46 M
454.76 M
13.01 M
505.16 M
144.32 M
14.72 M
Cash Flow From Operations
(32.66 M)
(40.53 M)
(523 K)
181.2 M
(31.82 M)
(426.57 K)
(24.05 M)
(1.46 M)
(8.13 M)
(1.04 M)
Total Debt
44.93 M
169.15 M
159.02 M
276.15 M
176.31 M
119.47 K
4.35 M
3.37 M
7.47 M
7.18 M
Return On Equity
-1.97
-0.48
-0.31
-0.0103
-1.07
N/A
-12.24
-12.09
-1.64
N/A
Z Score
N/A
N/A
0.6
1.8
1.8
4.5
-9.3
1.4
N/A
13.5
Return On Asset
-0.24
-0.0062
-0.0268
0.0291
-0.0244
-2.3
-1.76
-0.6
-0.22
-0.47
Book Value Per Share
0.068
1.41
1.27
4.58
1.06
-0.004
-0.36
-0.016
0.048
-1.22
Current Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
2.46 M
N/A
2.92 M
Total Asset
N/A
491.55 M
1.38 B
2.55 B
581.93 M
208.97 K
7.58 M
5.22 M
50.67 M
1.57 M
Debt To Equity
2.32
1.25
1.21
0.31
0.53
N/A
0.057
N/A
2.56
N/A
Target Price
N/A
4.3
4.13
42.1
2.75
N/A
140.0
0.05
N/A
N/A
Shares Owned By Institutions
0.01
0.03
2.36
3.0
5.7
N/A
N/A
N/A
N/A
N/A
Market Capitalization
22.57 M
82.65 M
300.07 M
992.41 M
531.41 M
2.96 M
5.94 M
26.77 M
540.18 K
1.05 M
Price To Earnings To Growth
N/A
N/A
-729.82
N/A
-0.86
N/A
N/A
N/A
N/A
N/A
Price To Earning
N/A
N/A
N/A
9.56
5.81
N/A
N/A
-10.0
N/A
0.72
Price To Sales
0.54
0.43
0.9
1.3
2.29
N/A
677.59
19.81
0.0772
1.33
Net Income
(165.72 M)
(73.16 M)
(143.1 M)
(14.68 M)
3.11 M
(875.48 K)
(28.9 M)
(4.13 M)
(26.63 M)
9.72 M
Earnings Per Share
-0.39
-0.64
-0.39
0.06
0.3
-0.005
-4.68
-0.018
-0.15
0.09
Shares Owned By Insiders
1.51
8.17
12.03
18.86
4.31
18.63
8.71
5.59
14.09
16.28
Revenue
36.47 M
188.86 M
460.08 M
737.85 M
210.42 M
N/A
7.49 K
1.28 M
7.21 M
889.9 K
Working Capital
N/A
N/A
N/A
N/A
N/A
N/A
N/A
(2.34 M)
N/A
(2.82 M)
Cash And Equivalents
5.46 M
32.64 M
52.48 M
92.83 M
52.5 M
24.26 K
324.15 K
6.56 K
2.36 M
46.6 K
Cash Per Share
0.01
277.53
0.13
0.28
0.21
N/A
0.04
N/A
0.02
N/A
Gross Profit
(9.56 M)
95.88 M
201.68 M
415.55 M
115.57 M
N/A
7.49 K
503.01 K
3.98 M
610.57 K
Day Typical Price
0.0151
0.0047
0.45
1.21
1.54
0.0015
0.0043
0.0087
2.0E-4
0.0325
Accumulation Distribution
N/A
0.33
0.087
0.056
0.0506
0.29
0.5
0.16
N/A
0.0676
Market Facilitation Index
N/A
0.002
0.04
0.07
0.08
5.0E-4
0.003
0.0015
N/A
0.0023
Daily Balance Of Power
0.0
N/A
0.5
(0.29)
(0.38)
0.2
(0.33)
(0.67)
(9,223,372,036,855)
(1.39)
Period Momentum Indicator
N/A
N/A
0.02
(0.02)
(0.03)
1.0E-4
(0)
(0)
(0.0009)
(0)
Rate Of Daily Change
1.0
1.0
1.05
0.98
0.98
1.06
0.8
0.89
0.18
0.91
Day Median Price
0.0151
0.005
0.44
1.21
1.54
0.0014
0.0045
0.0088
2.0E-4
0.0329
Price Action Indicator
N/A
(0)
0.03
(0.03)
(0.01)
3.0E-4
(0)
(0.0008)
(0.0004)
(0)
Coefficient Of Variation
812.4
(573.04)
5557.72
(504.95)
6533.23
(1,550)
697.73
(4,023)
436.95
(3,702)
Mean Deviation
0.0199
8.36
4.16
4.05
2.82
7.72
24.19
6.16
87.01
5.87
Jensen Alpha
(0.0002)
(2.62)
0.1147
(1.30)
0.0246
(0.68)
4.61
(0.24)
40.63
(0.25)
Total Risk Alpha
(0)
(3.06)
(0.07)
(1.51)
(0.06)
(0.95)
3.89
(0.46)
36.14
(0.48)
Sortino Ratio
N/A
N/A
0.012
N/A
0.0059
N/A
0.1534
N/A
0.4933
N/A
Downside Variance
N/A
N/A
51.02
N/A
16.22
N/A
983.33
N/A
6949.66
N/A
Standard Deviation
0.0821
15.05
6.54
6.62
3.66
10.2
33.78
8.51
179.81
8.55
Kurtosis
66.0
19.89
4.61
8.54
(0.29)
0.0919
1.97
0.4155
27.39
0.7623
Potential Upside
N/A
11.11
10.53
6.56
6.83
17.65
55.56
15.84
450.0
15.89
Treynor Ratio
0.0071
3.84
(0.34)
1.14
0.0477
(1.06)
0.4767
(0.23)
1.78
(0.84)
Maximum Drawdown
0.6667
117.0
39.88
38.88
15.51
42.45
180.56
36.65
1292.31
45.86
Variance
0.0067
226.61
42.81
43.84
13.41
104.07
1141.05
72.38
32333.3
73.12
Market Risk Adjusted Performance
0.0171
3.85
(0.33)
1.15
0.0577
(1.05)
0.4867
(0.22)
1.79
(0.83)
Risk Adjusted Performance
0.011
(0.13)
0.0231
(0.15)
0.02
(0.04)
0.124
(0.01)
0.1924
(0.01)
Skewness
8.12
(3.70)
0.0191
(0.82)
0.1943
0.2654
1.15
0.0894
4.8
0.0544
Semi Deviation
N/A
N/A
5.68
N/A
3.35
N/A
19.61
N/A
26.51
N/A
Information Ratio
(0.27)
(0.18)
0.0131
(0.20)
0.0065
(0.07)
0.1424
(0.03)
0.2287
(0.03)
Value At Risk
N/A
(16.67)
(6.52)
(8.52)
(5.99)
(15.91)
(33.93)
(14.53)
(81.82)
(13.98)
Expected Short fall
N/A
N/A
(5.84)
N/A
(3.26)
N/A
(49.11)
N/A
(360.19)
N/A
Downside Deviation
N/A
N/A
7.14
N/A
4.03
N/A
31.36
N/A
83.36
N/A
Semi Variance
N/A
N/A
32.24
N/A
11.21
N/A
384.52
N/A
702.72
N/A

Aleafia Health Competition Performance Charts

Five steps to successful analysis of Aleafia Health Competition

Aleafia Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Aleafia Health in relation to its competition. Aleafia Health's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Aleafia Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Aleafia Health's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Aleafia Health, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Aleafia Health position

In addition to having Aleafia Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Healthcare Thematic Idea Now

Healthcare
Healthcare Theme
Companies that provide healthcare goods and services including hospitals, health maintenance organizations, HMOs, or medical aid manufacturers. The Healthcare theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Consideration for investing in Aleafia Pink Sheet

If you are still planning to invest in Aleafia Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aleafia Health's history and understand the potential risks before investing.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
CEOs Directory
Screen CEOs from public companies around the world
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Global Correlations
Find global opportunities by holding instruments from different markets
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY